Share Name Share Symbol Market Type Share ISIN Share Description
Kidde Plc LSE:KID London Ordinary Share GB0000154020 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p - - - - - - - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Unknown - - - - 0.00

Kidde Plc (KID) Latest News

Real-Time news about Kidde Plc (London Stock Exchange): 0 recent articles
More Kidde Plc News
Kidde Plc Takeover Rumours

Kidde Plc (KID) Share Charts

1 Year Kidde Plc Chart

1 Year Kidde Plc Chart

1 Month Kidde Plc Chart

1 Month Kidde Plc Chart

Intraday Kidde Plc Chart

Intraday Kidde Plc Chart

Kidde Plc (KID) Discussions and Chat

Kidde Plc Forums and Chat

Date Time Title Posts
16/10/200519:39Kidde watchers?4
17/1/200508:45The Kidde Thread51

Add a New Thread

Kidde Plc (KID) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Kidde Plc trades in real-time

Kidde Plc (KID) Top Chat Posts

m5artin: ROC is an AIM share here but can be included in an ISA because it is listed on the Australian stock exchange. When the next round starts put me down for ROC. They are an oil company. I think Oil shares are going to remain strong. The Russians think oil is going to be progressivly more expensive. ROC's share price is managing to continue to rise even in this bad market. ROC have some good prospects. It is worth listening to the latest presentation I was especially interested by Angola Also nice is thata the ROC bulletin board shows overnight action down under, which gives an indication of which way the price is going. And of course everyone is hoping for a succesful outcome in China.
robin_of_loxley: true wcjan25.....I have posted on OXB board that there may be short term concerns in share price again re OXB.....may fall more before rises again a la SKP....
robin_of_loxley: Oxford BioMedica Trovax results due Monday; company upbeat on licensing deal LONDON (AFX) - Oxford BioMedica PLC, a developer of gene-based medicines, will on Monday announce new data on Trovax, its lead drug currently being tested in three separate Phase II trials for use in colorectal cancer. Nick Woolf, Oxford Bio's senior vice president of corporate strategy, told AFX News he is confident the news will be positive and believes they are close to finding a partner to help fund expensive late stage clinical trials and commercialise the drug once approved. Oxford BioMedica has been searching for a development partner for Trovax for a couple of years. It is also being tested for use in renal cancer. "We're very confident we can get a deal done in '06. It may be this side of Christmas, but more likely to be next year," he said, speaking at the European BioPartnering Conference in London yesterday. He said Oxford BioMedica has been holding talks with "multinational" drug companies. Positive data and eventual news of a licensing partner is likely to help the company's share price, which has already more than doubled this year, from 17.5 pence at the beginning of the year to 42.4 pence today. The company has a market value of 155 mln stg. After interim results in August analyst Jon Senior at Evolution Securities wrote in a note to clients: "Given that the final data from the crucial phase II trials is due soon and is likely to be followed by the anticipation of a licensing deal and the start of the phase III trials, we believe the momentum is likely to stay with BioMedica's share price." He has an 'add' recommendation on the stock. BioMedica's Woolf said the company plans to start Phase III trials in the middle of next year on their own, funded from company resources, even if they have not found a partner. They can only afford to fund one set of trials -- either in renal or colorectal cancer -- and will announce which will proceed next year, after agreeing the trial design with US regulators. "We'll start it on our own if necessary because we're confident a partner will be found," he said. Initial data from the colorectal trials, released in March, indicated that the drug was safe and producing an immune response in patients. Trovax works by making the immune system recognise a tumour as a foreign body and attack it. The new data will be presented at the International Colorectal Cancer Congress, in Florida, this weekend. According to the US National Cancer Institute colorectal cancer is the third most common cancer and the second leading cause of cancer related death in the US. Woolf also said that ProSavin, a treatment for Parkinson's disease with should enter the clinic next year, and RetinoStat for age-related macular degeneration, also in pre-clinical stages, have attracted interest from potential partners.
salmac: I am a latecomer to Kid Millionaires - a great idea. If it's not too late I should like to propose Dicom Group (DCM) a company that turns documents into information -see Between 2000 and 2004, turnover increased from £99.2m to £156.2m, operating profit from £4.7m to £12.9m and EPS from 29.3p to 45.0p. I am not a chartist but the share price has been in an uptrend since May. The price at close of play on Friday was 1008p. My vote would be ASM 25, DCM 50, OXB 25
m5artin: thanks for your analysis though I think some of the choices are way out. The charts show the share price declining or the news flow has gone sour!. Best to go with companies that have good news flow and a rising share price
seamush: Great idea wcjan. My second is a couple of months old and I've been looking around at various options but not really impressed with any. Taking control is a much better idea though whether she'll thank me for this in 18 years time I guess we'll have to wait and see :-) I've been in AEX for the last few weeks now and am fairly confident that a deal between the Yanks/N Korea/Japs/China/Russia will be sorted in the next round of talks. This should see the share price at least in the 20s, if not the 30s. I'm reluctant to predict anything higher for a while after that though the long term potential is most certainly there as a multi bagger. Cheers
tinker: Amazed how quiet this thread is now that UTC have made their offer under due diligence. Loads of CFD & Rule 8 activity but no-one here seems interested. It's only six weeks since articles like these were appearing in the heavies: LONDON, October 22 ( - Analysts at Arbuthnot Securities upgrade Kidde (AP55.ISE) from "buy" to "strong buy." In a research note published this morning, the analysts mention that Kidde has rejected an acquisition bid from UTC, saying that the bid was low, given the company's growth prospects. Honeywell and Siemens are likely to bid for Kidde in the near future, the analysts say. Arbuthnot Securities expects Kidde's share price to appreciate significantly in the near term. Telegraph October 22: "It is understood that the US (UTC) group, which already holds a 2.6 per cent stake in Kidde, is not considering launching a hostile bid. Instead, it intends to play a waiting game and see where Kidde's share price settles in the coming weeks. Nevertheless, analysts believe it will have to increase its offer if it is going to be successful. According to Harry Philips, an analyst at Williams de Broe, the 160p-a-share offer puts Kidde on an multiple of 15.5 times earnings, "not enough for a knockout punch". On Friday, shares in Kidde closed at 170p, indicating that the market believes a higher offer will materialise. There has been speculation that a rival bid could emerge, with US industrial groups General Electric and Honeywell, as well as Siemens, the German industrial group, seen as potential bidders." Anyone around??
mr.oz: Investors put £1.5bn tag on Kidde By Sylvia Pfeifer (Filed: 24/10/2004) Shareholders in Kidde, the fire protection group, have indicated they would be prepared to sell out if United Technologies Corporation (UTC), the US industrial conglomerate, increases its takeover offer from 160p to 180p a share. Last week, Kidde rejected UTC's 160p offer as too low, saying it materially undervalued the company and its prospects. A 180p a share, an offer would value Kidde at just over £1.5bn. "We would like to see this conclude with a bid," said one leading shareholder with a holding of over 5 per cent. "A 160p-a-share bid is not a runner for the company to open its books. I think management is of the view that, if we get a fair price, they would be happy to sell. Somewhere between 180p and 185p." Another leading shareholder added: "We are supporting the board. We believe it has approached the negotiations quite sensibly. However, our understanding is that if UTC came up with an offer of around 180p, the board would consider it." Investors' continued support for Kidde's management's decision to hold out for a higher offer will put pressure on UTC to increase its bid. UTC executives from the US are expected to fly to London this week to try to persuade investors of the merits of the 160p-a-share offer. It is understood that the US group, which already holds a 2.6 per cent stake in Kidde, is not considering launching a hostile bid. Instead, it intends to play a waiting game and see where Kidde's share price settles in the coming weeks. Nevertheless, analysts believe it will have to increase its offer if it is going to be successful. According to Harry Philips, an analyst at Williams de Broe, the 160p-a-share offer puts Kidde on an multiple of 15.5 times earnings, "not enough for a knockout punch". On Friday, shares in Kidde closed at 170p, indicating that the market believes a higher offer will materialise. There has been speculation that a rival bid could emerge, with US industrial groups General Electric and Honeywell, as well as Siemens, the German industrial group, seen as potential bidders.
abcd1234: From The Independent today ... £2 fair price, others in the frame ... :O) Kidde board rejects £1.3bn takeover - UTC may go hostile 22 October 2004 United Technologies Corp (UTC) of the United States revealed yesterday that it had made an offer of about £1.3bn for Kidde, the fire prevention and protection group and that it might now launch a hostile bid. The British company was forced to make a statement after a sharp increase in its share price spurred by rumours of the approach. It said: "The board of Kidde announces that it recently received a preliminary approach from a third party in relation to a potential offer for the entire issued share capital of Kidde. However, the board has rejected the proposal made and no further proposal has been received." UTC later revealed that it would meet shareholders to persuade them to press the board into allowing it access to the UK group's books in order to carry out due diligence. It did not rule out the possibility of a hostile takeover bid. Kidde shares closed up 17 per cent at 145p and UTC's potential offer represents a significant premium to Kidde's share price ahead of the frenzied speculation. UTC said that it felt an offer of 160p a share represented a full price for the company, representing 14 times earning before interest and appreciation. Kidde shares have more than doubled since the company was demerged from the former Williams conglomerate in late 2000. The other company spun off from Williams at the same time was Chubb, a security services business, which has already been bought by UTC. Michael Blogg, an analyst at Arbuthnot Securities, said that separating Kidde and Chubb had been a mistake, leaving both businesses with gaps in product lines and distribution. "It would be very interesting if this approach came from UTC. The industrial logic of splitting these companies [Kidde and Chubb] simply did not exist." If UTC did buy Kidde, it would effectively be putting the businesses back together. Mr Blogg said a successful approach may have to value Kidde as high as 200p a share or nearly £1.7bn. Others said that it did not matter who the initial approach came from as Kidde was now in play and a number of other suitors were likely to emerge. The US groups Tyco and Honeywell were mentioned as possible bidders. Harry Philips, an analyst at Williams de BroĆ«, said: "If it [the approach] had been at 200p they'd have to have put it to shareholders.... This is a cracking business with a lot of momentum behind." The aerospace market has shown signs of recovery for Kidde, while its residential arm is performing strongly. New legislation, especially in the US, drives demand for fire prevention and detection equipment. The Independent ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
abcd1234: From the Financial Times tomorrow..... :O), they rejected 160, what next...up to £2 is mentioned below .. :O))) United Technologies to pursue bid for Kidde By Dan Roberts in New York and Lisa Urquhart in London United Technologies is preparing to pursue a £1.3bn ($2.4bn) bid for Kidde, a UK-based fire alarm manufacturer, having seen an informal offer rejected by its management. The US industrial conglomerate is now considering an appeal directly to Kidde shareholders in an effort to allow it to conduct further due diligence. Following share price movements, Kidde first announced on Thursday that it had received an approach from an unnamed bidder. Despite Kidde's rejection of the proposal, shares in the fire protection group closed up 17 per cent at 145p as observers remained confident that a fresh bid would materialise On Thursday night, sources close to the talks confirmed the interest had come from United Technologies, which is believed to have made an indicative offer in the range of 160p per share. A successful bid would recombine two businesses that had been split apart by a previous owner, UK conglomerate Williams Group. Williams had demerged both Kidde and Chubb, a security equipment manufacturer which was later bought by United Technologies. Kidde is first thought to have been approached two weeks ago. On Thursday the group declined to comment further, other than saying said they had not received a fresh approach. Among the names of other rumoured suitors are Siemens, the German engineering group, and Honeywell. While Honeywell has a complimentary building controls and aerospace business, analysts were on Thursday pointing to UTC as the most likely bidder. One analyst said: "It makes sense given that they have previous history." Analysts, who described Kidde's fire protection activities as a unique business asset, said that bids could range from between 155p a share to 200p, valuing Kidde at £1.3bn-£1.68bn. Nick Wilson of Dresdner Kleinwort Wasserstein said the bid had come at a time when the management team was in state of change, following the announcement in September that Michael Harper, who has been chief executive since Kidde's flotation in 2000, would be retiring in January. The group has yet to appoint a new chief executive, and chairman Norman Askew has been in his position for less than 12 months. Kidde is, however, is strong financial position following the recent recovery of the aerospace industry. Earlier this year the group revealed that it had won a 20 year-contract worth about $250m to fit out Boeing's new 7E7 Dreamliner jets with fire protection. Kidde, which the market leader in residential fire protection in the US, has also recently benefited from legislation in New York City that requires carbon monoxide detectors in homes by November. At its interim results the group reported a 23 per cent increase in pre-tax profits to £33.4m. Financial Times ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ hmmm...... up to £2.00, ... now that would be nice, nothing like having more than one suitor is there
Kidde Plc share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180217 20:01:41